International Conference on Coagulation Disorders and Hemostasis
ICCDH
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This session will explore the latest innovations in diagnostic techniques for coagulation disorders. Emphasis will be placed on the integration of molecular studies and laboratory innovations to enhance patient outcomes.
SDG 3
SDG 4
This track will delve into the underlying mechanisms of thrombosis and its clinical implications. Discussions will focus on novel therapeutic strategies and their effectiveness in managing thrombotic conditions.
SDG 3
SDG 9
This session will address the importance of patient monitoring in the management of hemostatic disorders. Participants will review current practices and emerging technologies that facilitate real-time assessment of coagulation status.
SDG 3
SDG 9
This track will highlight the bridge between basic research and clinical application in hematology. Presentations will focus on how translational research is shaping new therapeutic approaches for coagulation disorders.
SDG 3
SDG 9
This session will provide insights into the design and outcomes of recent clinical trials targeting coagulation disorders. Experts will discuss challenges faced and future directions for research in this field.
SDG 3
SDG 9
This track will focus on the molecular mechanisms governing hemostasis and their implications for disease. Attendees will explore how molecular studies can inform therapeutic strategies and improve patient care.
SDG 3
SDG 9
This session will showcase cutting-edge laboratory techniques that enhance the diagnosis and management of coagulation disorders. Participants will learn about the latest tools and methodologies that improve accuracy and efficiency.
SDG 3
SDG 4
This track will address the unique challenges faced in diagnosing and treating coagulation disorders in pediatric populations. Discussions will focus on tailored approaches and innovative solutions for this vulnerable group.
SDG 3
SDG 4
This session will examine the genetic factors contributing to coagulation disorders and their implications for patient management. Participants will discuss advancements in genetic testing and personalized medicine.
SDG 3
SDG 4
This track will explore integrative approaches combining pharmacological and non-pharmacological strategies in managing hemostatic disorders. Emphasis will be placed on collaborative care models and interdisciplinary practices.
SDG 3
SDG 4
This session will provide a forward-looking perspective on emerging trends and future directions in hematology research. Participants will engage in discussions about potential breakthroughs and their implications for clinical practice.
SDG 3
SDG 4